From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 188,029 shares, representing 1.28% for $5 million under the buyback announced on April 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.33 USD | -1.52% | -2.58% | +11.78% |
30/05 | Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics | CI |
28/05 | Anika Therapeutics Approves $40 Million Share Repurchase Program | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.78% | 376M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.